Menu
Search
|

Menu

Close
X

Bioanalytical Systems Inc BASI.OQ (NASDAQ Stock Exchange Capital Market)

1.57 USD
-0.01 (-0.63%)
As of Feb 20
chart
Previous Close 1.58
Open 1.58
Volume 2,628
3m Avg Volume 11,381
Today’s High 1.62
Today’s Low 1.54
52 Week High 2.95
52 Week Low 0.99
Shares Outstanding (mil) 8.24
Market Capitalization (mil) 14.25
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, USD)
FY18
5
FY17
24
FY16
20
FY15
23
EPS (USD)
FY18
0.003
FY17
0.104
FY16
-0.398
FY15
0.118
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
0.61
5.77
Price to Book (MRQ)
vs sector
1.98
5.41
Price to Cash Flow (TTM)
vs sector
31.96
23.42
Total Debt to Equity (MRQ)
vs sector
59.75
16.52
LT Debt to Equity (MRQ)
vs sector
52.38
12.22
Return on Investment (TTM)
vs sector
-12.43
14.43
Return on Equity (TTM)
vs sector
-17.86
16.13

EXECUTIVE LEADERSHIP

Gregory Davis
Interim Chairman of the Board, Since 2017
Salary: --
Bonus: --
Jill Blumhoff
Chief Financial Officer, Vice President - Finance, Since 2016
Salary: --
Bonus: --
James Bourdage
Vice President - Bioanalytical Operations, Since 2014
Salary: $170,000.00
Bonus: --
Philip Downing
Vice President - Preclinical Services, Since 2015
Salary: --
Bonus: --
Connie Dougherty
Vice President - Business Development, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

2701 Kent Ave
WEST LAFAYETTE   IN   47906-1350

Phone: +1317.4634527

Bioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing.

SPONSORED STORIES